Pcn70 - Assessing the Budget Impact of Including Sunitinib for the Treatment of Metastatic Renal Cell Carcinoma in Argentina

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.152
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma

Therapeutic Advances in Urology
Urology
2016English

Hypertension as Predictor of Sunitinib Treatment Outcome in Metastatic Renal Cell Carcinoma

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2011English

Angiotensin Inhibitors as Treatment of Sunitinib/Pazopanib-Induced Hypertension in Metastatic Renal Cell Carcinoma

Clinical Genitourinary Cancer
OncologyUrology
2017English

Successful Treatment With Sorafenib for Sunitinib-Refractory Metastatic Papillary Renal Cell Carcinoma: Potential Impact of Raf Overexpression on Predicting the Efficacy of Sorafenib

IJU Case Reports
2018English

Phase I Trial of Sunitinib and Temsirolimus in Metastatic Renal Cell Carcinoma

Clinical Genitourinary Cancer
OncologyUrology
2015English

Long-Term Response to Sunitinib Therapy for Metastatic Renal Cell Carcinoma

Clinical Genitourinary Cancer
OncologyUrology
2013English

Mp16-01 Clinical Implications of Sunitinib and N-Desethyl-Sunitinib Plasma Concentrations for Treatment Outcome in Metastatic Renal Cell Carcinoma Patients

Journal of Urology
Urology
2017English

Nonablative Hematopoietic Cell Transplantation for the Treatment of Metastatic Renal Cell Carcinoma

Bone Marrow Transplantation
TransplantationHematology
2002English

Sunitinib in the Treatment of Renal Cell Carcinoma: An Update on Recent Evidence

Therapeutic Advances in Urology
Urology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy